Skip To Content

Study ID: NRG CC004

Title:

Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer

Description:
This is a trial of bupropion versus placebo for sexual desire in women with breast or gynecological cancers. The trial will be measuring the ability of two dose levels of bupropion to improve sexual desire more than a placebo at 9 weeks.
Location:
Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Cancer Control, Breast - Invasive, Endometrial, Gynecologic, Other, Ovary/Fallopian Tube/Primary Peritoneal, Vulvar, Cervix
Stage:
Phase II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.